StopDown
Honasa Consumer logo
Acquisition · 23 June 2026Honasa ConsumerDigital-first beauty and personal care brandshonasa.in ↗

Honasa acquires 58% stake in Fluence Pharma

By · Editor ·

Founded 2016
  • Honasa Consumer owns brands like Mamaearth and The Derma Co
  • It bought a 58% stake in Fluence Pharma for ₹135 Cr via secondary purchase
  • The deal helps Honasa enter the nutraceuticals market, valued at ₹16,000 Cr in India

What happened

  • Honasa Consumer's board approved the acquisition of a 58% stake in Fluence Pharma for ₹135 Cr.
  • The stake is bought via a secondary purchase from existing shareholders.
  • The transaction is expected to close within eight weeks.
  • Honasa will acquire the remaining 42% stake in two tranches over 5-7 years after the first phase.
  • Honasa's board also approved setting up a wholly-owned subsidiary called Honasa Health.
  • Honasa Health will build a nutraceuticals vertical with an initial paid-up capital of ₹1 lakh.
  • Honasa Health will combine Fluence Pharma's Cyclical Nutrition Therapy (CNT) platform with Honasa's distribution and marketing.

Why it matters

  • The acquisition aligns with Honasa's 3.0 strategy to double FY31 revenue to over ₹5,500 Cr and improve EBITDA margins above 15%.
  • Honasa sees nutraceuticals as the next phase of growth in beauty and personal care, with consumers seeking inside-out solutions.
  • India's nutraceuticals market is estimated at around ₹16,000 Cr.
  • Large competitors like L'Oréal, HUL, Marico, and ITC have also acquired nutraceutical or beauty brands recently.

The business

  • Honasa Consumer is a digital-first house of brands in beauty and personal care.
  • It owns 8 brands including Mamaearth, The Derma Co., Aqualogica, Lumineve, Staze, BBlunt, Dr Sheth's, and Reginald Men.
  • The company has an omni-channel presence across 750+ districts in India.
  • Honasa plans to scale offline distribution from ~1.2 lakh outlets to over 3 lakh outlets.
  • It projects Mamaearth revenue to exceed ₹2,000 Cr and The Derma Co. to cross ₹1,500 Cr by FY31.
  • Honasa aims to build at least two additional brands with annual revenue over ₹500 Cr each.
  • The company sees nutraceuticals, fragrances, and oral care as key next-horizon categories.

The founders

Ghazal Alagh

Co-founder
in
  • Co-founded Honasa Consumer in 2016.
  • No other background details provided in the facts.

Varun Alagh

Co-founder & CEO
in
  • Co-founded Honasa Consumer in 2016.
  • Serves as CEO of the company.
  • Stated that nutraceuticals is the next phase of growth in beauty and personal care.

Amit Bhusari

Co-founder of Fluence Pharma
  • Co-founded Fluence Pharma in 2012.
  • No other background details provided in the facts.

Dr Rajendra Singh Rajput

Co-founder of Fluence Pharma
  • Co-founded Fluence Pharma in 2012.
  • No other background details provided in the facts.

In numbers

58%Stake acquired in Fluence Pharma · 2026
₹135 CrAcquisition amount · 2026
₹37.2 CrFluence Pharma FY25 turnover · 2025
₹40 CrFluence Pharma FY26 revenue · 2026
over 20%Fluence Pharma FY26 EBITDA margin · 2026
over 70%Revenue from hair-focused products · 2026
₹200.2 CrHonasa FY26 net profit · 2026
₹2,391.9 CrHonasa FY26 operating revenue · 2026
over ₹5,500 CrHonasa FY31 revenue target · 2031
₹16,000 CrIndia nutraceuticals market size · 2026

What happens next

  • Honasa Health will be led by Dheeraj Nagpal, ex-co-founder of Zingavita.
  • Honasa plans to scale offline distribution from ~1.2 lakh outlets to over 3 lakh outlets.
  • The company aims to build at least two additional brands with annual revenue over ₹500 Cr each.
  • Honasa will explore nutraceuticals, fragrances, and oral care as next-horizon categories.

Earlier rounds

  • December 2025 · acquisition · Undisclosed · led by Honasa Consumer

Up against

L'OréalHULUSVMaricoITC

Words to know

Secondary purchase
Buying shares from existing shareholders rather than from the company itself; the money goes to the sellers, not the company.
Nutraceuticals
Products derived from food sources with extra health benefits, like dietary supplements and functional foods.
Cyclical Nutrition Therapy (CNT)
A patented platform by Fluence Pharma that uses a cycle-based approach to deliver nutrients for skin and hair health.
EBITDA margin
A measure of a company's operating profitability, calculated as earnings before interest, taxes, depreciation, and amortisation divided by revenue.

The numbers around it

Honasa Consumer has 1 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
5 January 2022Growth round$52 MUndefined

Commerce & Consumer Brands in June 2026: 24 rounds with a disclosed amount, $298 million in all; the biggest was FirstClub ($55M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.
  • Valuation: A private startup does not have a net worth you can look up. It has a valuation: a price tied to a funding round, a share sale or a company statement. Net worth means assets minus debts, and it belongs to people and listed companies. In Indian news, valued at usually points to a recent deal.

Everything on Honasa Consumer → · All startup news on 23 June 2026 →

Is this Honasa Consumer? Get your “Featured on StopDown” badge →